ATE307117T1 - Succinoylaminolactamderivate als inhibitoren der a beta protein produktion - Google Patents
Succinoylaminolactamderivate als inhibitoren der a beta protein produktionInfo
- Publication number
- ATE307117T1 ATE307117T1 AT99939010T AT99939010T ATE307117T1 AT E307117 T1 ATE307117 T1 AT E307117T1 AT 99939010 T AT99939010 T AT 99939010T AT 99939010 T AT99939010 T AT 99939010T AT E307117 T1 ATE307117 T1 AT E307117T1
- Authority
- AT
- Austria
- Prior art keywords
- succinoylaminolactam
- inhibitors
- derivatives
- protein production
- beta protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/12—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9569898P | 1998-08-07 | 1998-08-07 | |
US11355898P | 1998-12-24 | 1998-12-24 | |
US12022799P | 1999-02-15 | 1999-02-15 | |
PCT/US1999/017717 WO2000007995A1 (en) | 1998-08-07 | 1999-08-07 | SUCCINOYLAMINO LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE307117T1 true ATE307117T1 (de) | 2005-11-15 |
Family
ID=27377979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99939010T ATE307117T1 (de) | 1998-08-07 | 1999-08-07 | Succinoylaminolactamderivate als inhibitoren der a beta protein produktion |
Country Status (14)
Country | Link |
---|---|
US (2) | US7304055B2 (de) |
EP (1) | EP1102752B1 (de) |
JP (1) | JP2003526603A (de) |
CN (1) | CN1311779A (de) |
AR (1) | AR024197A1 (de) |
AT (1) | ATE307117T1 (de) |
AU (1) | AU756830B2 (de) |
BR (1) | BR9912969A (de) |
CA (1) | CA2338944A1 (de) |
DE (1) | DE69927827T2 (de) |
ES (1) | ES2251838T3 (de) |
HR (1) | HRP990246A2 (de) |
TR (1) | TR200100377T2 (de) |
WO (1) | WO2000007995A1 (de) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU778005B2 (en) * | 1998-12-24 | 2004-11-11 | Bristol-Myers Squibb Pharma Company | Succinoylamino benzodiazepines as inhibitors of Abeta protein production |
MXPA02001813A (es) | 1999-09-13 | 2004-03-19 | Bristol Myers Squibb Pharma Co | Hidroxialcanoilaminolactamas y estructuras relacionas como inhibidores de la produccion de la proteina abeta. |
US6503902B2 (en) | 1999-09-13 | 2003-01-07 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production |
US6960576B2 (en) | 1999-09-13 | 2005-11-01 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production |
EP1218377A1 (de) * | 1999-10-08 | 2002-07-03 | Bristol-Myers Squibb Pharma Company | Amino-lactam-sulfonamide als inhibitoren der bildung von a-beta-amyloid-protein |
AU2001239791A1 (en) * | 2000-02-17 | 2001-08-27 | Du Pont Pharmaceuticals Company | Succinoylamino carbocycles and heterocycles as inhibitors of abeta protein production |
WO2001072324A1 (en) * | 2000-03-28 | 2001-10-04 | Bristol-Myers Squibb Pharma Company | Lactams as inhibitors of a-beta protein production |
US6495540B2 (en) | 2000-03-28 | 2002-12-17 | Bristol - Myers Squibb Pharma Company | Lactams as inhibitors of A-β protein production |
WO2001074784A1 (en) * | 2000-04-03 | 2001-10-11 | Dupont Pharmaceuticals Company | CYCLIC LACTAMS AS INHIBITORS OF A-β PROTEIN PRODUCTION |
CA2404273A1 (en) | 2000-04-11 | 2001-10-18 | Bristol-Myers Squibb Pharma Company | Substituted lactams as inhibitors of a.beta. protein production |
AU2001261728A1 (en) * | 2000-05-17 | 2001-11-26 | Bristol-Myers Squibb Pharma Company | Use of small molecule radioligands for diagnostic imaging |
KR20020097484A (ko) * | 2000-05-19 | 2002-12-31 | 다케다 야쿠힌 고교 가부시키가이샤 | β-씨크리타아제 억제제 |
GB0012671D0 (en) | 2000-05-24 | 2000-07-19 | Merck Sharp & Dohme | Therapeutic agents |
CN1386118A (zh) * | 2000-06-01 | 2002-12-18 | 布里斯托尔-迈尔斯斯奎布药品公司 | 作为Aβ蛋白产生抑制剂的被环状琥珀酸酯取代的内酰胺类化合物 |
DE10043282A1 (de) * | 2000-09-02 | 2002-03-28 | Kurt Heininger | Verwendung von Inhibitoren der Amyloid-beta-Protein-Bildung |
US7001901B2 (en) | 2002-08-27 | 2006-02-21 | Bristol-Myers Squibb Company | Tetrazolylpropionamides as inhibitors of Aβ protein production |
TW200502221A (en) | 2002-10-03 | 2005-01-16 | Astrazeneca Ab | Novel lactams and uses thereof |
GB0223039D0 (en) * | 2002-10-04 | 2002-11-13 | Merck Sharp & Dohme | Therapeutic compounds |
GB0223038D0 (en) * | 2002-10-04 | 2002-11-13 | Merck Sharp & Dohme | Therapeutic compounds |
WO2004080983A1 (en) * | 2003-03-14 | 2004-09-23 | Astrazeneca Ab | Novel lactams and uses thereof |
TW200524910A (en) | 2003-08-08 | 2005-08-01 | Schering Corp | Cyclic amine BACE-1 inhibitors having a heterocyclic substituent |
ATE424383T1 (de) | 2003-08-08 | 2009-03-15 | Schering Corp | Cyclische amine mit benzamidsubstituent als bace- 1-inhibitoren |
WO2005019227A1 (en) * | 2003-08-22 | 2005-03-03 | Orchid Chemicals & Pharmaceuticals Ltd | Process for the preparation of cephalosporin antibiotic |
EP2279741A3 (de) * | 2003-12-01 | 2011-06-01 | Cambridge Enterprise Ltd. | Caprolactame und deren Verwendung als entzündungshemmende Mittel |
WO2005123669A1 (en) | 2004-06-10 | 2005-12-29 | Board Of Trustees Of Michigan State University | Synthesis of caprolactam from lysine |
ATE491693T1 (de) | 2004-07-22 | 2011-01-15 | Schering Corp | Substituierte amide als inhibitoren der beta- sekretase |
AU2006203946B2 (en) * | 2005-01-03 | 2009-07-23 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
US20100204230A1 (en) | 2007-02-12 | 2010-08-12 | Peter Blurton | Piperazine derivatives for treatment of ad and related conditions |
EP2148856B8 (de) * | 2007-02-20 | 2016-04-06 | Board of Trustees of Michigan State University | Katalytische Deaminierung zur Herstellung von Caprolactam |
MX2010006972A (es) | 2007-12-21 | 2010-08-26 | Ligand Pharm Inc | Moduladores selectivos de receptores de andrógenos (sarm) y usos de los mismos. |
US8461389B2 (en) | 2008-04-18 | 2013-06-11 | University College Dublin, National University Of Ireland, Dublin | Psycho-pharmaceuticals |
BRPI0911733A8 (pt) * | 2008-07-24 | 2017-10-03 | Amyris Inc | Método para produzir uma amida cíclica, método para produzir uma poliamida, método para produzir a-amino-e-caprolactama, método para produzir e-caprolactama, método para produzir policaprolactama, processo para a síntese de a-amino-e-caprolactama, processo para a síntese da e-caprolactama e método para produzir nylon 6 |
GB201101331D0 (en) * | 2011-01-26 | 2011-03-09 | Glaxosmithkline Biolog Sa | Compositions and uses |
JP5855583B2 (ja) * | 2011-01-07 | 2016-02-09 | セイコーエプソン株式会社 | 抗シグナルペプチド抗体の製造方法 |
TWI530489B (zh) | 2011-03-22 | 2016-04-21 | 必治妥美雅史谷比公司 | 雙(氟烷基)-1,4-苯二氮呯酮化合物 |
WO2014047392A1 (en) | 2012-09-21 | 2014-03-27 | Bristol-Myers Squibb Company | Fluoroalkyl-1,4-benzodiazepinone compounds |
JP2015531792A (ja) | 2012-09-21 | 2015-11-05 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | 1,4−ベンゾジアゼピノン化合物のプロドラッグ |
US9242941B2 (en) | 2012-09-21 | 2016-01-26 | Bristol-Myers Squibb Company | Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds |
EP2897944B1 (de) | 2012-09-21 | 2016-10-26 | Bristol-Myers Squibb Company | Substituierte 1,5-benzodiazepinon-verbindungen |
TWI614238B (zh) * | 2012-09-21 | 2018-02-11 | 必治妥美雅史谷比公司 | 雙(氟烷基)-1,4-苯并二氮呯酮化合物及其前藥 |
US9133126B2 (en) | 2012-09-21 | 2015-09-15 | Bristol-Myers Squibb Company | Fluoroalkyl dibenzoazepinone compounds |
JP2015533811A (ja) * | 2012-09-21 | 2015-11-26 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | N−置換ビス(フルオロアルキル)1,4−ベンゾジアゼピノン化合物 |
WO2014047390A1 (en) | 2012-09-21 | 2014-03-27 | Bristol-Myers Squibb Company | Tricyclic heterocyclic compounds as notch inhibitors |
WO2014047397A1 (en) * | 2012-09-21 | 2014-03-27 | Bristol-Myers Squibb Company | Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds as notch|inhibitors |
WO2014165718A1 (en) | 2013-04-04 | 2014-10-09 | Bristol-Myers Squibb Company | Combination therapy for the treatment of proliferative diseases |
EP3094323A4 (de) | 2014-01-17 | 2017-10-11 | Ligand Pharmaceuticals Incorporated | Verfahren und zusammensetzungen zur modulierung von hormonspiegeln |
Family Cites Families (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US552419A (en) * | 1895-12-31 | Gas generator and burner | ||
US4666829A (en) * | 1985-05-15 | 1987-05-19 | University Of California | Polypeptide marker for Alzheimer's disease and its use for diagnosis |
ZW23187A1 (en) | 1986-12-15 | 1988-06-29 | Hoffmann La Roche | Phosphinic acid derivatives |
FR2630440B1 (fr) * | 1988-04-25 | 1991-09-20 | Jouveinal Sa | Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique |
DE69017302T3 (de) * | 1989-08-04 | 1999-08-05 | Merck Sharp & Dohme | Zentrale Cholecystokinin-Antagonisten zur Behandlung von psychiatrischen Krankheiten. |
CA2026856A1 (en) | 1989-10-05 | 1991-04-06 | Mark G. Bock | 3-substituted-1,4-benzodiazepines useful as oxytocin |
US5175159A (en) * | 1989-10-05 | 1992-12-29 | Merck & Co., Inc. | 3-substituted-1,4-benzodiazepines as oxytocin antagonists |
IE904560A1 (en) | 1989-12-18 | 1991-06-19 | Merck & Co Inc | New benzodiazepine analogs |
US5019724A (en) | 1989-12-20 | 1991-05-28 | Sgs-Thomson Microelectronics, Inc. | Noise tolerant input buffer |
US5252463A (en) | 1990-06-22 | 1993-10-12 | The Du Pont Merck Pharmaceutical Company | Clipsin, a chymotrypsin-like protease and method of using same |
GB9022117D0 (en) | 1990-10-11 | 1990-11-21 | Beecham Group Plc | Novel compounds |
GB9107368D0 (en) | 1991-04-08 | 1991-05-22 | Smithkline Beecham Plc | Novel compounds |
US5538845A (en) * | 1992-02-05 | 1996-07-23 | Athena Neurosciences, Inc. | Beta-amyloid peptide production inhibitors and methods for their identification |
US5766846A (en) * | 1992-07-10 | 1998-06-16 | Athena Neurosciences | Methods of screening for compounds which inhibit soluble β-amyloid peptide production |
JP3457312B2 (ja) | 1992-07-29 | 2003-10-14 | メルク シヤープ エンド ドーム リミテツド | ベンゾジアセピン誘導体 |
US5283241A (en) | 1992-08-28 | 1994-02-01 | Merck & Co., Inc. | Benzo-fused lactams promote release of growth hormone |
KR100318572B1 (ko) | 1992-12-21 | 2002-04-22 | 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 | 비시클릭피브리노겐길항제 |
MX9308016A (es) * | 1992-12-22 | 1994-08-31 | Lilly Co Eli | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. |
US5455258A (en) | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
US5552419A (en) * | 1993-01-06 | 1996-09-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
US5506242A (en) * | 1993-01-06 | 1996-04-09 | Ciba-Geigy Corporation | Arylsufonamido-substituted hydroxamic acids |
JPH07157470A (ja) * | 1993-03-18 | 1995-06-20 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
US5594006A (en) * | 1993-03-18 | 1997-01-14 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives as matrix metalloproteinases inhibitors |
JPH09500615A (ja) * | 1993-05-14 | 1997-01-21 | ジェネンテク,インコーポレイテッド | Ras−ファルネシル転移酵素阻害剤 |
WO1994029273A1 (en) * | 1993-06-09 | 1994-12-22 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
IL110525A0 (en) * | 1993-08-09 | 1994-11-11 | Lilly Co Eli | Identification and use of protease inhibitors |
US5602156A (en) * | 1993-09-17 | 1997-02-11 | The United States Of America As Represented By The Department Of Health And Human Services | Method for inhibiting metalloproteinase expression |
US5545735A (en) | 1993-10-04 | 1996-08-13 | Merck & Co., Inc. | Benzo-Fused Lactams promote release of growth hormone |
US5426185A (en) * | 1993-11-22 | 1995-06-20 | Merck & Co., Inc. | Antiarrhythmic benzodiazepines |
US5770573A (en) * | 1993-12-06 | 1998-06-23 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
GB9401919D0 (en) * | 1994-02-01 | 1994-03-30 | Bridport Aviat Prod | Luggage bins for the cabins of passenger aircraft |
US5514716A (en) | 1994-02-25 | 1996-05-07 | Sterling Winthrop, Inc. | Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
EP0804425A2 (de) * | 1994-07-29 | 1997-11-05 | Fujisawa Pharmaceutical Co., Ltd. | Benzodiazepine derivatives |
US5661161A (en) * | 1994-09-29 | 1997-08-26 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
EP0796252A4 (de) | 1994-12-09 | 1998-02-04 | Smithkline Beecham Corp | Bicyclische fibrinogen antagonisten |
EP0799189A4 (de) * | 1994-12-13 | 1999-03-17 | Smithkline Beecham Corp | Bicyclische fibrinogen-antagonisten |
US5639746A (en) | 1994-12-29 | 1997-06-17 | The Procter & Gamble Company | Hydroxamic acid-containing inhibitors of matrix metalloproteases |
US5672598A (en) * | 1995-03-21 | 1997-09-30 | The Procter & Gamble Company | Lactam-containing hydroxamic acids |
US5578629A (en) * | 1995-03-29 | 1996-11-26 | Merck & Co., Inc. | Benzamide-containing inhibitors of farnesyl-protein transferase |
US5856326A (en) * | 1995-03-29 | 1999-01-05 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
GB9507799D0 (en) * | 1995-04-18 | 1995-05-31 | British Biotech Pharm | Metalloproteinase inhibitors |
WO1996038471A1 (en) * | 1995-05-29 | 1996-12-05 | Pfizer Inc. | Dipeptides which promote release of growth hormone |
US5710171A (en) * | 1995-05-24 | 1998-01-20 | Merck & Co., Inc. | Bisphenyl inhibitors of farnesyl-protein transferase |
US5756528A (en) * | 1995-06-06 | 1998-05-26 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
DE19522899C1 (de) * | 1995-06-23 | 1996-12-19 | Hexal Pharmaforschung Gmbh | Verfahren zum kontinuierlichen Ersintern eines Granulats |
JPH09188631A (ja) * | 1995-09-08 | 1997-07-22 | Kanebo Ltd | Fasリガンド可溶化抑制薬 |
EP0761680A3 (de) * | 1995-09-12 | 1999-05-06 | Ono Pharmaceutical Co., Ltd. | Tetrazolverbindungen mit Interleukin-1beta-konvertierendes Enzym inhibierende Aktivität |
WO1997012861A1 (en) | 1995-10-05 | 1997-04-10 | Chiroscience Limited | Mercaptoamide derivatives and their therapeutic use |
IL124366A0 (en) | 1995-11-14 | 1998-12-06 | Du Pont Merck Pharma | Novel macrocyclic compounds as metalloprotease inhibitors |
JP2000500761A (ja) * | 1995-11-23 | 2000-01-25 | ブリティッシュ バイオテック ファーマシューティカルズ リミテッド | 金属タンパク質分解酵素阻害剤 |
US5968965A (en) * | 1996-01-30 | 1999-10-19 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US6066738A (en) * | 1996-01-30 | 2000-05-23 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US6001835A (en) * | 1996-04-03 | 1999-12-14 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5885995A (en) * | 1996-04-03 | 1999-03-23 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
EP0891360A4 (de) | 1996-04-03 | 2002-05-15 | Merck & Co Inc | Inhibitoren der farnesyl-protein transferase |
US5891889A (en) * | 1996-04-03 | 1999-04-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5919785A (en) * | 1996-04-03 | 1999-07-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5852010A (en) * | 1996-04-03 | 1998-12-22 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5859012A (en) * | 1996-04-03 | 1999-01-12 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
WO1997036879A1 (en) | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
AU707416B2 (en) | 1996-04-03 | 1999-07-08 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5869682A (en) * | 1996-04-03 | 1999-02-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5965578A (en) * | 1996-04-03 | 1999-10-12 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
DE19614100C2 (de) * | 1996-04-10 | 2000-12-07 | Bosch Gmbh Robert | Vorrichtung zur Ermittlung des Zustandes eines Wischerblattes |
WO1997038664A2 (en) | 1996-04-18 | 1997-10-23 | Merck & Co., Inc. | A method of treating cancer |
JP2000508335A (ja) | 1996-05-30 | 2000-07-04 | メルク エンド カンパニー インコーポレーテッド | 癌の治療方法 |
US5703129A (en) * | 1996-09-30 | 1997-12-30 | Bristol-Myers Squibb Company | 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production |
WO1998015828A1 (en) | 1996-10-07 | 1998-04-16 | Scios Inc. | Method to identify direct inhibitors of the beta-amyloid forming enzyme gamma-secretase |
US6262047B1 (en) * | 1996-10-11 | 2001-07-17 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
JP2001504810A (ja) | 1996-10-11 | 2001-04-10 | シーオーアール・セラピューティックス・インコーポレーテッド | 選択的第Xa因子阻害剤 |
US5734054A (en) * | 1996-11-05 | 1998-03-31 | Pharmacopeia, Inc. | Hydroxy-amino acid amides |
DE19647382A1 (de) * | 1996-11-15 | 1998-05-20 | Hoechst Ag | Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten |
AU5354398A (en) | 1996-11-22 | 1998-06-10 | Elan Pharmaceuticals, Inc. | N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions compri sing same, and methods for inhibiting beta-amyloid peptide release and/or it s synthesis by use of such compounds |
JP2001508408A (ja) | 1996-11-22 | 2001-06-26 | エラン・ファーマシューティカルズ・インコーポレイテッド | N―(アリール/ヘテロアリール)アミノ酸エステル、医薬組成物およびベータ―アミロイドペプチドの放出および/またはその合成を阻害する方法 |
CN1238760A (zh) | 1996-11-22 | 1999-12-15 | 伊兰药品公司 | N-(芳基/杂芳基/烷基乙酰基)氨基酸酰胺类,含有这类化合物的药物组合物,及用这类化合物抑制β-淀粉样肽释放和或合成的方法 |
TR199901128T2 (xx) | 1996-11-22 | 1999-07-21 | Elan Pharmaceuticals, Inc. | N-(aril/heteroarilasetil) amino asit esterler, bunu ihtiva eden farmas�tik bile�imler ve bu t�r bile�ikler kullanarak �-amiloit peptit sal�n�m�n� ve/veya bunun sentezlenmesini inhibe etme y�ntemleri. |
TW523506B (en) | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
EP0951466B1 (de) * | 1996-12-23 | 2009-01-21 | Elan Pharmaceuticals, Inc. | Cycloalkyl-, lactam-, lacton- und verwandte verbindungen als hemmer der beta-amyloidpeptidfreisetzung |
US6093737A (en) * | 1996-12-30 | 2000-07-25 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
JP2002511054A (ja) | 1996-12-30 | 2002-04-09 | メルク エンド カンパニー インコーポレーテッド | ファルネシル蛋白トランスフェラーゼ阻害薬 |
JP2002241368A (ja) * | 1997-02-18 | 2002-08-28 | Shionogi & Co Ltd | 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物 |
US6432947B1 (en) * | 1997-02-19 | 2002-08-13 | Berlex Laboratories, Inc. | N-heterocyclic derivatives as NOS inhibitors |
US5985900A (en) * | 1997-04-01 | 1999-11-16 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
US6060038A (en) * | 1997-05-15 | 2000-05-09 | Merck & Co., Inc. | Radiolabeled farnesyl-protein transferase inhibitors |
DE19726427A1 (de) * | 1997-06-23 | 1998-12-24 | Boehringer Mannheim Gmbh | Pyrimidin-2,4,6-trion-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
GB9715030D0 (en) * | 1997-07-18 | 1997-09-24 | British Biotech Pharm | Metalloproteinase inhibitors |
US6228854B1 (en) * | 1997-08-11 | 2001-05-08 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
US6333321B1 (en) * | 1997-08-11 | 2001-12-25 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
US6297239B1 (en) * | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
US6440965B1 (en) * | 1997-10-15 | 2002-08-27 | Krenitsky Pharmaceuticals, Inc. | Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
-
1999
- 1999-08-06 HR HR990246A patent/HRP990246A2/hr not_active Application Discontinuation
- 1999-08-07 CA CA002338944A patent/CA2338944A1/en not_active Abandoned
- 1999-08-07 WO PCT/US1999/017717 patent/WO2000007995A1/en active IP Right Grant
- 1999-08-07 TR TR2001/00377T patent/TR200100377T2/xx unknown
- 1999-08-07 DE DE69927827T patent/DE69927827T2/de not_active Expired - Lifetime
- 1999-08-07 CN CN99809366A patent/CN1311779A/zh active Pending
- 1999-08-07 AT AT99939010T patent/ATE307117T1/de not_active IP Right Cessation
- 1999-08-07 JP JP2000563629A patent/JP2003526603A/ja not_active Ceased
- 1999-08-07 EP EP99939010A patent/EP1102752B1/de not_active Expired - Lifetime
- 1999-08-07 AU AU53378/99A patent/AU756830B2/en not_active Ceased
- 1999-08-07 ES ES99939010T patent/ES2251838T3/es not_active Expired - Lifetime
- 1999-08-07 BR BR9912969-8A patent/BR9912969A/pt not_active IP Right Cessation
- 1999-08-09 AR ARP990103962A patent/AR024197A1/es not_active Application Discontinuation
-
2006
- 2006-07-25 US US11/492,593 patent/US7304055B2/en not_active Expired - Lifetime
- 2006-07-26 US US11/493,156 patent/US7304056B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US7304056B2 (en) | 2007-12-04 |
AU5337899A (en) | 2000-02-28 |
DE69927827T2 (de) | 2006-07-06 |
US7304055B2 (en) | 2007-12-04 |
US20060258638A1 (en) | 2006-11-16 |
CN1311779A (zh) | 2001-09-05 |
AR024197A1 (es) | 2002-09-25 |
EP1102752B1 (de) | 2005-10-19 |
EP1102752A1 (de) | 2001-05-30 |
BR9912969A (pt) | 2001-09-25 |
WO2000007995A1 (en) | 2000-02-17 |
AU756830B2 (en) | 2003-01-23 |
ES2251838T3 (es) | 2006-05-01 |
HRP990246A2 (en) | 2000-06-30 |
CA2338944A1 (en) | 2000-02-17 |
TR200100377T2 (tr) | 2001-06-21 |
DE69927827D1 (de) | 2006-03-02 |
US20060264417A1 (en) | 2006-11-23 |
JP2003526603A (ja) | 2003-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69927827D1 (de) | Succinoylaminolactamderivate als inhibitoren der a beta protein produktion | |
PT1077957E (pt) | Derivados do acido oxi-iminoalcanoico | |
NO20006115D0 (no) | Nytt 3-aryl-2-hydroksypropionsyrederivat (I) | |
ATE248812T1 (de) | Arylsulfonylhydroxamsäurederivate | |
DK1003720T3 (da) | Aryloxyarylsulfonylaminohydroxamsyrederivater | |
NO20006114D0 (no) | Nytt 3-aryl-2-hydroksypropionsyrederivat III | |
NO994791D0 (no) | Nikotinamid-derivater | |
IS5338A (is) | Ný spíróasabísýklísk heterósýklísk efnasambönd | |
DE69906311D1 (de) | Diarylbenzopyranderivate als cyclooxygenase-2-inhibitoren | |
DE69809446T2 (de) | Azetidinonderivate als beta-lactamase-inhibitoren | |
DE60035631D1 (de) | Inhibitoren der Interleukin-4 Produktion | |
PT1237857E (pt) | Novos derivados fenalquiloxi-fenilo | |
ID19754A (id) | Metode untuk memproduksi formal siklik secara kontinyu | |
IS5562A (is) | Nýjar díhýdroxýhexanósýru afleiður | |
EE200000138A (et) | Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena | |
ATE233253T1 (de) | Chromanderivate | |
EE200000137A (et) | Pürrolopürrolooni derivaadid neutrofiili elastaasi inhibiitoritena | |
ATE262517T1 (de) | Thiopyranderivate as mmp-inhibitoren | |
TR200002831A3 (tr) | Kinolin-4-Il türevleri I | |
ID24327A (id) | Produksi senyawa-senyawa avermektin | |
NO994386D0 (no) | 2-substituerte benzoylcykloalkyl-1-karboksylsyrederivater | |
NO20022971D0 (no) | Butyndiol-derivater | |
NO20022682L (no) | Heterosykliske derivater | |
FI974001A (fi) | Uudet metyleenibisfosfonihappojohdannaiset | |
EE9900585A (et) | 6-asauratsiili derivaadid IL-5 inhibiitoritena |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1102752 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |